March 11, 2026
1 min read

Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China

The $3 billion investment will take shape over the next ten years, the company said, and will increase the global supply of its oral GLP-1 prospect orforglipron.

Leave a Reply

Your email address will not be published.

Previous Story

LabelBlind: India’s packaged foods hit by nutrition label noncompliance amid sector boom

Next Story

Red states hit hardest by reduced NIH funding

Previous Story

LabelBlind: India’s packaged foods hit by nutrition label noncompliance amid sector boom

Next Story

Red states hit hardest by reduced NIH funding

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop